The complex challenges of HIV vaccine development require renewed and expanded global commitment

Affiliations

• ¹ The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa. Electronic address: linda-gail.bekker@hiv-research.org.za.
• ² International AIDS Society, Geneva, Switzerland.
• ³ France Recherche Nord and Sud Sida-HIV Hépatites, Paris, France.
• ⁴ International AIDS Vaccine Initiative, New York, NY, USA.
• ⁵ Medical Research Council/Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
• ⁶ National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
• ⁷ Africa Health Research Institute, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
• ⁸ Bill & Melinda Gates Foundation, Seattle, WA, USA.
• ⁹ Treatment Action Group, New York, NY, USA.
• ¹⁰ AIDS Vaccine Advocacy Coalition, New York, NY, USA.
• ¹¹ National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; Center for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
• ¹² Service of Immunology and Allergy and Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
• ¹³ Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
• ¹⁴ South African Medical Research Council, Cape Town, South Africa.
• ¹⁵ World Health Organization, Geneva, Switzerland.
• ¹⁶ International Vaccine Institute, Seoul, South Korea.
• ¹⁷ Vaccine Research Institute, Creteil, France; INSERM U955, University Paris-Est Créteil, Créteil, France.
• ¹⁸ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ¹⁹ Department of Medicine, Imperial College London, London, UK.
• ²⁰ European and Developing Countries Clinical Trials Partnership, The Hague, Netherlands.
• ²¹ Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
• ²² The Office of AIDS Research, National Institutes of Health, Bethesda, MD, USA.
• ²³ State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.